In an effort to reduce risk to patients, regulatory agencies now require rigorous analysis of QT intervals in clinical trials as a measure of drug safety. This seminar will discuss the various ways to evaluate cardiac safety using a variety of methods - as early as preclinical and throughout your clinical trials.